The effects of AuDHD are real. Recognising the overlap of Autism and Attention Deficit Hyperactivity Disorder (ADHD), is ...
Using heart rate variability as a potential biomarker for diagnostic support and early screening of schizophrenia and bipolar ...
Q4 2025 Earnings Call Transcript September 23, 2025 Operator: Greetings. Welcome to the Aytu BioPharma, Inc. report for ...
Experts say that attention does not really "break"—it adapts. With practice, focus can be rebuilt despite digital ...
Health Secretary Robert F. Kennedy Jr. is working on policy changes to the Vaccine Injury Compensation Program that would ...
The fight for “We the People” and “one nation” is laced in complex, repetitive wounds we’re not always sure how to sew shut.
Wilmington-based Predicate AI Labs Inc. has entered a collaboration with the Mayo Clinic to advance the early detection of ...
The contest, presented by the Windansea Surf Club on Saturday, Oct. 4, at La Jolla Shores, invites children 16 and younger to ...
Hosted on MSN
White-collar work is breaking people's brains. Some are turning to unorthodox coaches for a fix.
In 2022, Sage Quiamno was in her early 30s and a few months into a demanding DEI leadership role at Amazon when she hit a wall. Cycles of feeling overwhelmed, procrastination, and frantic catch-up ...
AstraZeneca announces EMA committee recommends approval of Koselugo to treat plexiform neurofibromas in adults with neurofibromatosis type 1: Cambridge, UK Tuesday, September 23, ...
Teva received Fast Track designation from the U.S. Food and Drug Administration for emrusolmin (TEV-56286), an investigational treatment for Multiple System Atrophy (MSA) in Phase 2 development. New ...
Teva received Fast Track designation from the U.S. Food and Drug Administration for emrusolmin (TEV-56286), an investigational treatment for Multiple System Atrophy (MSA) in Phase 2 development.New th ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback